US Supreme Court considers shielding vaccine makers from "design defect" cases
This article was originally published in SRA
Executive Summary
Should vaccine manufacturers answer to jury trials in injuries cases, or are they protected by an existing federal compensation scheme? This was the nub of the arguments presented in a high-stakes case before the US Supreme Court in mid-October. The industry is closely watching the case to see if it sets some sort of nationwide precedent. A ruling could come next year.